Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Mesh:Combination"" wg kryterium: Temat


Tytuł :
Characteristics and Management of IgA Vasculitis (Henoch-Schonlein) in Adults Data From 260 Patients Included in a French Multicenter Retrospective Survey
Autorzy :
Audemard-Verger, Alexandra
Terrier, Benjamin
Dechartres, Agnes
Chanal, Johan
Amoura, Zahir
Le Gouellec, Noemie
Cacoub, Patrice
Jourde-Chiche, Noemie
Urbanski, Geoffrey
Augusto, Jean-Francois
Moulis, Guillaume
Raffray, Loic
Deroux, Alban
Hummel, Aurelie
Lioger, Bertrand
Catroux, Melanie
Faguer, Stanislas
Goutte, Julie
Martis, Nihal
Maurier, Francois
Riviere, Etienne
Sanges, Sebastien
Baldolli, Aurelie
Costedoat-Chalumeau, Nathalie
Roriz, Melanie
Puechal, Xavier
Andre, Marc
Lavigne, Christian
Bienvenu, Boris
Mekinian, Arsene
Zagdoun, Elie
Girard, Charlotte
Berezne, Alice
Guillevin, Loic
Thervet, Eric
Pillebout, Evangeline
Pokaż więcej
Temat :
Mesh:Middle Aged
Mesh:Humans
Mesh:Surveys and Questionnaires
Mesh:Antirheumatic Agents/therapeutic use
Mesh:Aged
Mesh:Arthralgia/epidemiology
Sciences du Vivant [q-bio]
Mesh:Drug Therapy
Mesh:IGA/epidemiology
Mesh:Treatment Outcome
Mesh:Arthralgia/etiology
Mesh:Combination
Mesh:Cyclophosphamide/therapeutic use
Mesh:Colchicine/therapeutic use
Mesh:Adult
Mesh:Logistic Models
Mesh:Glomerulonephritis
Mesh:Gastrointestinal Diseases/etiology
Mesh:Gastrointestinal Diseases/epidemiology
Mesh:IGA/etiology
Mesh:Schoenlein-Henoch/drug therapy
Mesh:Propensity Score
Mesh:Schoenlein-Henoch/complications
Mesh:Adrenal Cortex Hormones/therapeutic use
Mesh:Female
Mesh:France/epidemiology
Mesh:Schoenlein-Henoch/pathology
Mesh:Retrospective Studies
Mesh:Male
Mesh:Purpura
Mesh:Multivariate Analysis
Tytuł :
Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patients
Autorzy :
Mekinian, Arsene
Dervin, Guillaume
Lapidus, Nathanael
Kahn, Jean Emmannuel
Terriou, Louis
Liozon, Eric
Grignano, Eric
Piette, Jean-Charles
Rauzy Odile, Beyne
Grobost, Vincent
Godmer, Pascal
Gillard, Jerome
Rossignol, Julien
Launay, David
Aouba, Achille
Cardon, Thierry
Bouillet, Laurence
Broner, Jonathan
Vinit, Julien
Ades, Lionel
Carrat, Fabrice
Salvado, Clementine
Toussirot, Eric
Versini, Mathilde
Costedoat-Chalumeau, Nathalie
Fraison, Jean-Baptiste
Guilpain, Philippe
Fenaux, Pierre
Fain, Olivier
Pokaż więcej
Temat :
Mesh:Middle Aged
Mesh:Rheumatoid/mortality
Mesh:Polychondritis
Mesh:Humans
Mesh:Arthritis
Mesh:Disease-Free Survival
Mesh:Rituximab/pharmacology
Mesh:Rituximab/therapeutic use
Mesh:Relapsing/mortality
Mesh:Antirheumatic Agents/therapeutic use
Mesh:Aged
Mesh:Biological Products/therapeutic use
Sciences du Vivant [q-bio]
Mesh:Drug Therapy
Mesh:Humanized/therapeutic use
Corticosteroids
Mesh:Treatment Outcome
Mesh:Antirheumatic Agents/pharmacology
Mesh:Combination
Mesh:Myelodysplastic Syndromes/mortality
Mesh:Biological Products/pharmacology
Mesh:Myelodysplastic Syndromes/drug therapy
Mesh:Relapsing/drug therapy
Mesh:Monoclonal
Biologics
Vasculitis
Mesh:Rheumatoid/drug therapy
Mesh:Humanized/pharmacology
Relapsing polychondritis
Mesh:Female
Mesh:Antibodies
Arthritis
Mesh:France
Mesh:Retrospective Studies
Mesh:Male
Myelodysplastic syndrome
Mesh:Immunologic Factors/therapeutic use
Tytuł :
Efficacy and safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation (ANRS HC29 BOCEPRETRANSPLANT)
Autorzy :
Fontaine, Helene
Maynard, Marianne
Bouix, Cecile
Carrieri Maria, Patrizia
Botta-Fridlund, Danielle
D'alteroche, Louis
Conti, Filomena
Pageaux, Georges-Philippe
Leroy, Vincent
Metivier, Sophie
Anty, Rodolphe
Durand, Francois
Canva, Valerie
Vilotitch, Antoine
Lebray, Pascal
Alric, Laurent
Duvoux, Christophe
Petrov-Sanchez, Ventzislava
Beaulieux, Frederik
Wellems, Celia
Paul, Christelle
Roque-Afonso, Anne-Marie
Roche, Bruno
Pradat, Pierre
Samuel, Didier
Duclos-Vallee, Jean-Charles
Pokaż więcej
Temat :
Mesh:Middle Aged
Mesh:Liver Neoplasms/drug therapy
Mesh:Interferon-alpha/therapeutic use
Mesh:Proline/analogs & derivatives
Mesh:Humans
Mesh:Chronic/drug therapy
Mesh:Quality of Life
Mesh:Chronic/complications
Mesh:Hepatocellular/diagnosis
Mesh:Liver Transplantation
Mesh:Liver Cirrhosis/diagnosis
Mesh:Aged
Sciences du Vivant [q-bio]
Mesh:Hepatitis C
Mesh:Antiviral Agents/therapeutic use
Mesh:Drug Therapy
Mesh:Treatment Outcome
Mesh:Liver Neoplasms/mortality
Mesh:Liver Cirrhosis/drug therapy
Mesh:Liver Neoplasms/diagnosis
Mesh:Combination
Mesh:Adult
Mesh:Hepatocellular/complications
Mesh:Ribavirin/therapeutic use
Mesh:Liver Cirrhosis/mortality
Mesh:Hepatocellular/mortality
Mesh:Liver Cirrhosis/virology
Mesh:Hepatocellular/drug therapy
Mesh:Proline/therapeutic use
Mesh:Adolescent
Mesh:Female
Mesh:Liver Neoplasms/complications
Mesh:France
Mesh:Retrospective Studies
Mesh:Carcinoma
Mesh:Male
Mesh:Chronic/diagnosis
Mesh:Chronic/mortality
Tytuł :
Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis
Autorzy :
Carbonnel, Franck
Colombel, Jean-Frederic
Filippi, Jerome
Katsanos Konstantinos, H
Peyrin-Biroulet, Laurent
Allez, Matthieu
Nachury, Maria
Novacek, Gottfried
Danese, Silvio
Abitbol, Vered
Bossa, Fabrizio
Moreau, Jacques
Bommelaer, Gilles
Bourreille, Arnaud
Fumery, Mathurin
Roblin, Xavier
Reinisch, Walter
Bouhnik, Yoram
Brixi, Hedia
Seksik, Philippe
Malamut, Georgia
Farkkila, Martti
Coulibaly, Baya
Dewit, Olivier
Louis, Edouard
Deplanque, Dominique
Michetti, Pierre
Sarter, Hélène
Laharie, David
Pokaż więcej
Temat :
Mesh:Middle Aged
Mesh:Time Factors
Mesh:Ulcerative/drug therapy
Mesh:Humans
Mesh:Colon/pathology
Mesh:Subcutaneous
Mesh:Injections
Methotrexate
Mesh:Colitis
Drug
Sciences du Vivant [q-bio]
Mesh:Drug Therapy
Mesh:Treatment Outcome
Mesh:Colon/drug effects
Mesh:Combination
Mesh:Adult
Mesh:Remission Induction
Mesh:Adrenal Cortex Hormones/adverse effects
Clinical Trial
Mesh:Gastrointestinal Agents/therapeutic use
Mesh:Anti-Inflammatory Agents/administration & dosage
Mesh:Methotrexate/adverse effects
Mesh:Ulcerative/diagnosis
Mesh:Wound Healing/drug effects
Mesh:Anti-Inflammatory Agents/adverse effects
IBD
Mesh:Gastrointestinal Agents/adverse effects
Mesh:Adrenal Cortex Hormones/therapeutic use
Mesh:Gastrointestinal Agents/administration & dosage
Mesh:Intramuscular
Mesh:Female
Mesh:Methotrexate/administration & dosage
Mesh:Methotrexate/therapeutic use
Mesh:Europe
Mesh:Male
Mesh:Double-Blind Method
Mesh:Anti-Inflammatory Agents/therapeutic use
Tytuł :
Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study
Autorzy :
Mekinian, Arsene
Grignano, Eric
Braun, Thorsten
Decaux, Olivier
Liozon, Eric
Costedoat-Chalumeau, Nathalie
Kahn, Jean Emmannuel
Hamidou, Mohamed
Park, Sophie
Puechal, Xavier
Toussirot, Eric
Falgarone, Geraldine
Launay, David
Morel, Nathalie
Trouiller, Sebastien
Mathian, Alexis
Gombert, Bruno
Schoindre, Yoland
Lioger, Bertrand
De Wazieres, Benoit
Amoura, Zahir
Buchdahl, Anne-Laure
Georgin-Lavialle, Sophie
Dion, Jeremie
Madaule, Serge
Raffray, Loic
Cathebras, Pascal
Piette, Jean-Charles
Rose, Christian
Ziza, Jean-Marc
Lortholary, Olivier
Montestruc, Francois
Omouri, Mohammed
Denis, Guillaume
Rossignol, Julien
Nimubona, Stanislas
Ades, Lionel
Gardin, Claude
Fenaux, Pierre
Fain, Olivier
Pokaż więcej
Temat :
Mesh:Inflammation/immunology
Mesh:Glucocorticoids/therapeutic use
treatment
Mesh:Azacitidine/therapeutic use
Mesh:Antineoplastic/therapeutic use
Mesh:Humans
Mesh:Inflammation/etiology
Mesh:Antimetabolites
Mesh:Chronic/complications
Mesh:Aged
Mesh:Autoimmunity/immunology
Sciences du Vivant [q-bio]
Mesh:Drug Therapy
Mesh:Combination
Mesh:Prognosis
outcome
autoimmune disorders
Mesh:Myelodysplastic Syndromes/immunology
Mesh:Inflammation/drug therapy
Mesh:Female
Mesh:Myelodysplastic Syndromes/complications
Mesh:France
Mesh:Retrospective Studies
Mesh:Myelomonocytic
Mesh:Male
Mesh:Myelodysplastic Syndromes/drug therapy
Mesh:Chronic/drug therapy
Mesh:Follow-Up Studies
myelodysplastic syndrome
Mesh:Leukemia
Mesh:Chronic/immunology
Tytuł :
Efficacy of Biological-Targeted Treatments in Takayasu Arteritis Multicenter, Retrospective Study of 49 Patients
Autorzy :
Mekinian, Arsene
Comarmond, Cloe
Resche-Rigon, Matthieu
Mirault, Tristan
Kahn, Jean Emmannuel
Lambert, Marc
Sibilia, Jean
Neel, Antoine
Cohen, Pascal
Hie, Miguel
Berthier, Sabine
Marie, Isabelle
Lavigne, Christian
Anne Vandenhende, Marie
Muller, Geraldine
Amoura, Zahir
Devilliers, Herve
Abad, Sebastien
Hamidou, Mohamed
Guillevin, Loic
Dhote, Robin
Godeau, Bertrand
Messas, Emmanuel
Cacoub, Patrice
Fain, Olivier
Saadoun, David
Pokaż więcej
Temat :
Mesh:Adalimumab/therapeutic use
Mesh:Middle Aged
Mesh:C-Reactive Protein/analysis
Mesh:Infliximab/therapeutic use
Mesh:Tumor Necrosis Factor-alpha/antagonists & inhibitors
Mesh:Humans
Mesh:Disease-Free Survival
Mesh:Infliximab/adverse effects
Mesh:Prednisone/therapeutic use
Mesh:Proportional Hazards Models
Mesh:Antirheumatic Agents/therapeutic use
Mesh:Antirheumatic Agents/adverse effects
Mesh:Humanized/adverse effects
Sciences du Vivant [q-bio]
Mesh:Humanized/therapeutic use
Mesh:Drug Therapy
Mesh:Takayasu Arteritis/blood
Mesh:Treatment Outcome
Mesh:Drug Resistance
Takayasu arteritis
Mesh:Combination
Mesh:Takayasu Arteritis/diagnostic imaging
Mesh:Adult
Mesh:Drug Evaluation
Mesh:Monoclonal
Mesh:Molecular Targeted Therapy*/adverse effects
vasculitis
Mesh:Young Adult
biological therapy
Mesh:Blood Sedimentation
treatment outcome
Mesh:Female
Mesh:Antibodies
Mesh:Angiography
Mesh:Retrospective Studies
Mesh:Male
Mesh:Etanercept/therapeutic use
Mesh:Takayasu Arteritis/drug therapy
Mesh:Etanercept/adverse effects
Mesh:Adalimumab/adverse effects

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies